Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab

NCT01542866 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT01542866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01542866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab
Lead sponsor
Novartis Pharmaceuticals
Phase
Not applicable
Overall status
Completed
Start date
January 11, 2011
Completion date
November 30, 2011
Enrollment
160 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration (amd)